INTERVIEW FEED & ADDITIVE MAGAZINE January 2025 59 Thierry Duvanel, Bühler’s Director of Innovation, Dr. Gil Ronen, CEO and Co-Founder of NRGene and Dr. Ben Gradus, Director of Product, BSF at NRGene Canada share the details. The importance of alternative proteins, especially insect-based proteins, and investments in this field are increasing day by day. Bühler and NRGene are two prominent companies actively working in this area. Can you tell us about the role and position of these two companies in the insectbased protein market? Thierry Duvanel, Bühler: Bühler and NRGene offer complementary services for those who want to become BSF-based product producers (Protein, Oil, FRASS). Bühler is the leading provider of technology for the growing and processing of insects, including Black Soldier Fly (BSF). Bühler develops and delivers entire processing plants encompassing the rearing, growing and processing of insects into protein meals, oils and FRASS. Dr. Ben Gradus, NRGene Canada: NRGene acts upstream and specializes in developing custom-made, genetically improved (non-GMO) BSF strains tailored for specific production needs. By leveraging cutting-edge AI-driven genomics, NRGene enhances the efficiency of BSF breeding, ensuring maximum yield and profitability for production facility owners. Together, these companies provide a holistic solution. With a focus on the animal feed industry, can you explain the importance of alternative proteins in terms of global food safety, sustainability and circular economy? Dr. Ben Gradus, NRGene Canada: The animal feed sector is undergoing a major transformation driven by the need for more sustainable practices in animal management. Alternative proteins, particularly insect-based proteins like those derived from BSF, are key in addressing global challenges in food safety, sustainability, and the circular economy. Insect proteins offer a reliable and sustainable alternative to conventional feed ingredients like soy Dr. Ben Gradus Director of Product, BSF at NRGene Canada Thierry Duvanel Bühler's Director of Innovation Dr. Gil Ronen CEO & Co-Founder of NRGene
RkJQdWJsaXNoZXIy MTUxNjkxNQ==